Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Zirabev Drug Description: Detailed Datasheet
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: bevacizumab-bvzr injection
- Brand Name: Zirabev
- Drug Class: , Antineoplastics, VEGF Inhibitor
side effects drug center zirabev (bevacizumab-bvzr injection) drug
Drug Description
What is Zirabev and how is it used?
Zirabev (bevacizumab-bvzr) is a vascular endothelial growth factor inhibitor indicated for the treatment of metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment; and metastatic colorectal cancer, in combination with fluoropyrimidine¬irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for second-line treatment in patients who have progressed on a first-line bevacizumab product-containing regimen. Zirabev is biosimilar to Avastin (bevacizumab).
What are side effects of Zirabev?
Common side effects of Zirabev include:
- nosebleed,
- headache,